Myomo, Inc.

ASE: MYO
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Myomo, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get MYO Z-Score →

About Myomo, Inc.

Healthcare Medical Devices
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

📊 Fundamental Analysis

Myomo, Inc. demonstrates a profit margin of -38.1%, which is below the sector average, suggesting competitive pressure.

The company recently reported -5.9% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -86.2%, which indicates that capital utilization is currently under pressure.

At a current price of $0.69, MYO currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $0.60 - $4.99).

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$26.57M
Trailing P/E
--
Forward P/E
-2.63
Beta (5Y)
1.16
52W High
$4.99
52W Low
$0.60
Avg Volume
419K
Day High
Day Low
Get MYO Z-Score on Dashboard 🚀